Pure Global
NCT04483193

Reliability of Duplex Ultrasound for Diagnosis of Deep Vein Thrombosis Performed by Nurses

Reliability of Extended Duplex Ultrasound for Diagnosis of Proximal Deep Vein Thrombosis Performed by General Intensive Care Unit Nurses in the Critically Ill Patients
Emergency Medical Service of the Central Bohemian Region, Czech Republic·ClinicalTrials.gov·diagnostic testRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Ultrasound
Drug/Device/Intervention
Duplex ultrasound
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Emergency Medical Service of the Central Bohemian Region, Czech Republic
Location
Usti nad Labem, Czech
Timeline & enrollment
Phase
N/A
Start date
Jul 28, 2020
End date
Aug 31, 2021
Enrollment
500 participants
Primary outcome

Validity of duplex ultrasound

Summary

The purpose of this study is to assess validity of extended duplex ultrasound examination for
 diagnosis of proximal deep vein thrombosis performed by general intensive care unit nurses in
 the critically ill patients.

ICD-10 classifications
Abnormal ultrasonic finding on antenatal screening of motherAntenatal screening for malformations using ultrasound and other physical methodsAntenatal screening for fetal growth retardation using ultrasound and other physical methodsOther diagnostic agentsExamination of ears and hearing
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04483193
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04483193 through Pure Global AI's free database. This phase not specified trial is sponsored by Emergency Medical Service of the Central Bohemian Region, Czech Republic and is currently Recruiting. The study focuses on Ultrasound. Target enrollment is 500 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.